verywellhealth9h
Zunveyl: An Improved Alzheimer's Drug With Fewer Side Effects Will Be Available Soon
Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.
Discovery of new fungi compound leads to hope for potential dementia, Parkinson’s and depression drug
A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...
Monthly Prescribing Reference12h
Lecanemab SC Formulation Under Review for Early Alzheimer Disease
The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...
Hosted on MSN12d
Best Hearing Aids for Alzheimer’s Patients, Approved by Audiologists
Our Top PicksBest rechargeableJabra EnhanceBest basic optionsMDHearingEasiest insertionEargoHearing loss may affect cognition ...
China Medical System （00867）Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer’s Type
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
The best defense against Alzheimer’s disease is prevention | Opinion
Diet, exercise, brain games, even using your non-dominant hand can help prevent the onset of Alzheimer's disease.
Introducing FDI, the Florey Dementia Index for Alzheimer's onset prediction
A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...